… 2 The discipline of Cardio-Oncology (CO) has emerged, in particular, to prevent, mitigate, …
what constitutes a CV toxicity. Cardiovascular toxicities of cancer therapies encompass a …

… , especially cardiovascular toxicity. … consensus statement from the International Cardio-Oncology
Society based on general principles of radiotherapy delivery and cardiovascular …

… This work does not provide detailed information regarding the cardiovascular toxicities
associated with … However, there is no consensus on the use of cardiac biomarkers or the timing of …

… This expert consensus also acknowledged the use of global longitudinal strain as a … ,
prevention, and management of various cardiovascular toxicities. We remain in need of studies to …

… However, there is no consensus on how to define and assess cardiac contractility. As far
as assessment is concerned, despite universal adoption, left ventricular ejection fraction (LVEF) …

… cardiovascular toxicities are being reported with increasing frequency in part due to US Food
and Drug Administration and manufacturer recommended cardiac … cardiovascular toxicities …

… Recent reports provided greater insights into the incidence of cardiovascular adverse events
(… Physicians should be aware of these infrequent, but potentially fatal toxicities associated …

… cardiac toxicity can be an important complication both during and after cancer treatment.
Clinically, cardiac toxicity … experience acute or chronic cardiovascular adverse effects that could …

… cardiovascular complications from ICI therapy. The aim of this review is to describe cardiovascular
toxicities … consensus statements for temporal arteritis treatment. According to existing …

… Here, we report the cardiovascular toxicity profile associated with anti… strategies to prevent
toxicity and drive drug discovery. … In addition, an expert consensus document published by the …